OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

CORTEZ MASTO JOINS AMICUS BRIEF URGING FIFTH CIRCUIT TO REVERSE TEXAS DISTRICT COURT RULING RESTRICTING ACCESS TO ABORTION PILL

Press Release

Date: May 2, 2023
Location: Washington, D.C.
Issues: Abortion Judicial Branch

"FDA's determination that mifepristone is safe and effective is based on a thorough and comprehensive review process prescribed and overseen by the legislative branch. Since mifepristone's initial approval in 2000, FDA has repeatedly and consistently affirmed that the medication is safe and effective for its approved conditions of use. FDA's process and conclusions have been validated by both Congress and the Government Accountability Office--and by the lived experience of over 5 million patients who have used the drug in the United States."


Source
arrow_upward